Eisai Co., Ltd.
JPX: 4523.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Haruo Naito
- Employees
- 11,067
- Headquarters
- Tokyo, Japan
- IPO year
- 2000
- Market cap
- ¥1.3T
- Website
- https://www.eisai.co.jp
Loading 4523…
Loading profile data…Frequently asked questions about 4523
What does Eisai Co., Ltd. (4523.T) do?
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also prov...
Where does 4523.T trade?
Eisai Co., Ltd. (4523.T) trades on the Tokyo Stock Exchange.
What sector is 4523.T in?
Eisai Co., Ltd. (4523.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Eisai Co., Ltd.?
Haruo Naito is the chief executive officer of Eisai Co., Ltd. (4523.T).
Where is Eisai Co., Ltd. headquartered?
Eisai Co., Ltd. is headquartered in Japan.
Does 4523.T pay a dividend?
Yes — Eisai Co., Ltd. (4523.T) paid a trailing twelve-month dividend of JPY 160.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4523.T go public?
Eisai Co., Ltd. (4523.T) completed its initial public offering in 2000.